NCT01156376 – Determination of the oral irritation and sensitization potential of two experimental potassium oxalate containing mouth rinses Posted on August 31, 2017 by tsuperadmin -
NCT01226459 – A Phase 3, Multi-Center, Parallel Design Clinical Trial to Compare the Efficacy and Safety of 5% Minoxidil Foam versus vehicle in Females for the Treatment of Female Pattern Hair Loss (Androgenetic Alopecia) Posted on August 31, 2017 by tsuperadmin -
NCT01145625 – A Phase 3, Multi-Center, Parallel Design Clinical Trial to Compare the Efficacy and Safety of 5% Minoxidil Foam versus 2% Minoxidil Solution in Females for the Treatment of Female Pattern Hair Loss (Androgenetic Alopecia) Posted on August 31, 2017 by tsuperadmin -
NCT00786838 – A Study to Assess the Potential Effects of a Single-Dose Administration of Trabectedin on the QT Intervals of the Electrocardiogram Posted on August 24, 2017 by tsuperadmin -
NCT00210665 – A Study to Provide Access to Trabectedin in Participants With Locally Advanced or Metastatic Soft Tissue Sarcoma Who Have Persistent or Recurrent Disease and Who Are Not Expected to Benefit From Currently Available Standard of Care Treatment Posted on August 24, 2017 by tsuperadmin -
NCT00060944 – A Randomized, Multicenter, Open-label Study of Yondelis (ET-743 Ecteinascidin) Administered by 2 Different Schedules (Weekly for 3 of 4 Weeks vs. q3 Weeks) in Subjects With Locally Advanced or Metastatic Liposarcoma or Leiomyosarcoma Following Treatment With an Anthracycline and Ifosfamide Posted on August 24, 2017 by tsuperadmin -
NCT01343277 – A Study of Trabectedin or Dacarbazine for the Treatment of Patients With Advanced Liposarcoma or Leiomyosarcoma Posted on August 24, 2017 by tsuperadmin -
NCT00044681 – A Study to Evaluate the Efficacy, Safety and Maintenance Effect of Risperidone Augmentation of SSRI Monotherapy in Young and Older Adult Patients With Unipolar Treatment-Resistant Depression Posted on August 24, 2017 by tsuperadmin -
NCT00307437 – A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial Evaluating the Efficacy and Safety of CNTO 1275 in the Treatment of Subjects With Moderate to Severe Plaque-type Psoriasis Posted on May 9, 2017 by tsuperadmin -
The YODA Project